Related Experiment Videos
Pancytopenia in tuberous sclerosis
M Tashiro1, W Hirose, H Hanabusa
1Department of Internal Medicine, Urawa Municipal Hospital, Urawa, Saitama, Japan. mtashiro@mail.cc.tohoku.ac.jp
Summary
Tuberous sclerosis can cause severe anemia and pancytopenia due to bone marrow changes and hypersplenism. Surgical removal of the spleen improved the patient's condition, highlighting a potential treatment avenue.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Tuberous sclerosis (TS) is a rare genetic disorder characterized by the formation of benign tumors in various organs.
- Hematological abnormalities are not commonly reported in TS, making severe cases like this noteworthy.
Observation:
- A 46-year-old female patient presented with edema and pancytopenia.
- Clinical diagnosis of tuberous sclerosis was confirmed with characteristic manifestations including facial adenoma sebaceous, fibromas, subependymal nodules, and renal angiomyolipoma.
- Radiographic evidence showed significant cortical thickening of long bones and osteosclerotic vertebral findings, indicating reduced hematopoietic space.
Findings:
- Massive anemia contributed to hypercardiac function and edema.
- Pancytopenia was attributed to a combination of hypersplenism and reduced hematopoietic space.
- Splenectomy led to improvement in pancytopenia, though the direct link between intrasplenic hemangiomas and hypersplenism remained unclear.
Implications:
- This case underscores the potential for severe and diverse systemic complications in tuberous sclerosis.
- It highlights the critical role of hematological evaluation in TS patients presenting with cytopenias.
- The findings suggest that managing hypersplenism and addressing bone marrow involvement may be crucial for improving hematological parameters in TS.